Guidelines for Drug Product Stability Testing as per FDA Guidance
1) Purpose
The purpose of this Standard Operating Procedure (SOP) is to provide guidance on the application of the US FDA’s guidance for industry on drug product stability testing. This SOP ensures that the stability studies conducted are in compliance with the FDA requirements to support product quality and shelf-life determination.
2) Scope
This SOP applies to all personnel involved in the design, execution, and documentation of stability studies for drug products intended for the US market.
3) Responsibilities
Stability Testing Team: Responsible for conducting stability studies, collecting data, and documenting results according to FDA guidelines.
Quality Assurance (QA) Team: Responsible for reviewing and approving stability protocols and reports, ensuring compliance with FDA guidelines.
Regulatory Affairs Team: Responsible for ensuring that stability studies meet FDA regulatory expectations.
4) Procedure
4.1 Preparation for Stability Testing
4.1.1 Obtain and review
4.1.2 Develop a stability protocol that includes the study design, testing schedule, storage conditions, and testing parameters as per FDA guidelines.
4.2 Selection of Batches and Samples
4.2.1 Select representative batches of the product, typically three primary batches manufactured using the proposed production process.
4.2.2 Prepare sufficient
4.3 Defining Storage Conditions and Time Points
4.3.1 Define the storage conditions according to FDA guidelines, typically including:
- Long-term stability: 25°C ± 2°C/60% RH ± 5% RH
- Accelerated stability: 40°C ± 2°C/75% RH ± 5% RH
- Intermediate stability (if needed): 30°C ± 2°C/65% RH ± 5% RH
4.3.2 Establish the time points for sampling, such as 0, 3, 6, 9, 12, 18, and 24 months for long-term studies, and additional time points for accelerated studies.
4.4 Conducting Stability Tests
4.4.1 Store samples under the defined conditions, monitoring temperature and humidity to ensure compliance with the set parameters.
4.4.2 At each specified time point, remove samples and conduct stability-indicating tests, including physical, chemical, microbiological, and functional tests, as applicable.
4.4.3 Record all results meticulously in stability data sheets, ensuring accuracy and traceability of data.
5) Abbreviations, if any
FDA: United States Food and Drug Administration
QA: Quality Assurance
6) Documents, if any
Stability protocol, stability data sheets, stability testing records, stability report, submission package to FDA.
7) Reference, if any
FDA Guidance for Industry: Stability Testing of Drug Substances and Drug Products.
8) SOP Version
Version 1.0